Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Harron

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
American Journal of Hypertension|April 1, 1992
Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptorsD W Harron
Fundamental & Clinical Pharmacology|January 1, 1992
Clinical pharmacology of imidazolines and related compoundsD W Harron
Journal of Cardiovascular Pharmacology|January 1, 1986
Experimental evidence for the antiarrhythmic action of indoraminD W Harron
The American Journal of Medicine|September 18, 1989
Antihypertensive drugs and baroreflex sensitivity. Effects of rilmenidineD W Harron
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1984
Facilitation of the Bezold-Jarisch reflex by central stimulation of alpha 2 adrenoceptors in dogsD W Harron, W Kobinger
Basic Research in Cardiology|September 1, 1990
H2-receptor antagonism is not pro-arrhythmic in a chronic canine modelA C Uprichard, D W Harron
British Journal of Clinical Pharmacology|May 1, 1981
Comparison of the duration of effect of metoprolol and a sustained release formulation of metoprolol (betaloc-SA)D W Harron, R G Shanks
Clinical Pharmacology and Therapeutics|November 1, 1992
The effects of rilmenidine on tests of autonomic function in humansJ P McKaigue, D W Harron
British Journal of Clinical Pharmacology|October 1, 1990
Effect of UK-52,046, an alpha 1-adrenoceptor antagonist, on baroreflex function in manJ P McKaigue, D W Harron
Drugs|May 1, 1990
Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmiasD W Harron, R N Brogden
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
American Journal of Hypertension|April 1, 1992
Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptorsD W Harron
Fundamental & Clinical Pharmacology|January 1, 1992
Clinical pharmacology of imidazolines and related compoundsD W Harron
Journal of Cardiovascular Pharmacology|January 1, 1986
Experimental evidence for the antiarrhythmic action of indoraminD W Harron
The American Journal of Medicine|September 18, 1989
Antihypertensive drugs and baroreflex sensitivity. Effects of rilmenidineD W Harron
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1984
Facilitation of the Bezold-Jarisch reflex by central stimulation of alpha 2 adrenoceptors in dogsD W Harron, W Kobinger
Basic Research in Cardiology|September 1, 1990
H2-receptor antagonism is not pro-arrhythmic in a chronic canine modelA C Uprichard, D W Harron
British Journal of Clinical Pharmacology|May 1, 1981
Comparison of the duration of effect of metoprolol and a sustained release formulation of metoprolol (betaloc-SA)D W Harron, R G Shanks
Clinical Pharmacology and Therapeutics|November 1, 1992
The effects of rilmenidine on tests of autonomic function in humansJ P McKaigue, D W Harron
British Journal of Clinical Pharmacology|October 1, 1990
Effect of UK-52,046, an alpha 1-adrenoceptor antagonist, on baroreflex function in manJ P McKaigue, D W Harron
Drugs|May 1, 1990
Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmiasD W Harron, R N Brogden
Pageof 9